Professional Experience
Dr. Czarniecki leads robotic and focal prostate cancer treatments and advanced diagnostics in collaboration with international centers.
- Chair of Urology Clinic & Innovation Director at Carolina Medical Center, Warsaw
- Over 2,500 prostate fusion biopsies performed—among world leaders in volume
- Pioneered robotic and HIFU-based focal prostate cancer therapy in Central Europe
- Extensive international collaboration in the USA, Netherlands, Germany, France, and UK
Academic Contributions
- Co‑author of multicenter studies on liquid biopsy and prostate cancer diagnostics
- Presented at European Urology meetings including EAU Central European Meeting and imaging workshops
- Active in committees: EAU ESUI (imaging), ESUO, ERUS, and New Media for guideline dissemination
Areas of Expertise
Dr. Czarniecki offers precise diagnostics and targeted therapies in urology with strong focus on patient safety and effectiveness.
- Prostate cancer: MRI/US fusion-guided biopsy (transperineal), focal HIFU therapy, active surveillance strategies
- Robotic urology: prostatectomy, focal treatment with minimal side-effects
- Benign prostate conditions: TURP, TUIP, laser enucleation, urinary sphincter implantation, urethroplasty
- Reconstructive and general urology: circumcision, stenting, testicular biopsy, bladder tumour resection, nerve-sparing techniques
Publications and Research
Dr. Czarniecki contributes significantly to prostate cancer diagnostics and treatment literature.
He has published on topics including liquid biopsy for selective prostate cancer detection and patterns of care in bladder cancer within Polish cohorts. His work spans international collaborations and guideline dissemination in major journals and conferences.
Patient Care Philosophy
Dr. Czarniecki emphasizes personalized treatment planning, minimal invasiveness, and patient education. He is committed to reducing overtreatment while ensuring accurate diagnosis.
- Uses high‑precision diagnostics to tailor treatment—aims to preserve organ function when possible
- Provides guidance in English for international patients and supports cross-border referrals via Carolina Medical Center
- Advocates active surveillance and focal therapy over radical treatment in low‑risk cases
- Engages in social awareness campaigns on prostate cancer prevention and early diagnosis
Professional Affiliations
- Member of Polish Urological Association (PTU)
- Member of European Association of Urology (EAU); roles in ESUI, ESUO, ERUS
- Member of American Urological Association (AUA)
- Serves on EAU New Media Committee to enhance guideline outreach
FAQs
- Is Dr. Stefan Czarniecki board‑certified?
- Yes, he is Fellow of the European Board of Urology (FEBU) and certified by the Polish Urological Association since over a decade ago.
- What types of procedures does he perform?
- He performs MRI/US fusion prostate biopsy, focal HIFU therapy, robotic prostatectomy, TURP/TUIP, laser treatment for BPH, urethroplasty, urinary sphincter implants, and bladder tumour resections.
- Does he treat international patients?
- Yes. He offers English‑language consultations and Carolina Medical Center accepts international referrals and insurance arrangements.
- How long is the typical hospital stay?
- Fusion biopsy and focal procedures can often be done as day cases or short stays (around 2–3 hours). Major robotic or HIFU interventions may require longer monitoring.
- What languages does he speak?
- He speaks English and Polish fluently; clinic staff support international patients.
- Is focal HIFU therapy safe?
- Yes. The transperineal MRI‑guided biopsy and focal HIFU methods reduce infection risk (<0.01 %) and enable targeted prostate cancer treatment with minimal side effects.
- Does he follow active surveillance policies?
- Yes. For low‑risk prostate cancer patients, he advocates active surveillance as an option backed by advanced monitoring and imaging tools.
